About
Patient Care
Education
Research
Community
May 13, 2024 | UCI Beall Applied Innovation
Henry Klassen, M.D., Ph.D. Awarded Entrepreneurial Leader of the Year
Henry Klassen, M.D., Ph.D. Professor of Ophthalmology and Director of the Stem Cell & Retinal Regeneration, UCI School of Medicine, wins the Entrepreneurial Leader of the Year. UCI Beall Applied Innovation, with generous support from Don and Ken Beall, created the annual UCI Innovator Awards to recognize UCI researchers working actively to promote commercialization of university intellectual property, which supports industry growth and moves inventions from the lab to market to benefit humankind.
May 07, 2024 | Visgenx
ELOVL2 Enzyme Product Improves Retinal Function and Rejuvenates Retina Architecture in an Aged Mouse Model of AMD
The study, performed in the lab of Dr. Dorota Skowronska-Krawczyk at the University of California, Irvine, confirms the critical nature of the ELOVL2 enzyme.
Feb 22, 2024 | UCI News
UC Irvine study shows similarities and differences in human and insect vision formation
Discovery offers insights into retinal disease origins and potential therapeutic targets.
Matt Miller Director, Communications and Public Relations mrmille2@uci.edu
Michelle Strombeck Manager, Communications and Public Relations 312-498-8208 mstrombe@hs.uci.edu
Stay Connected
Following the UCI Office of Research’s official announcement last week that the Center for Translational Vision Research (CTVR) has achieved the prestigious Organized Research Unit (ORU) status at UCI, I want to thank everyone involved in working over the last five years to reach this significant milestone.
The Roger Steinert, MD, Legacy Award is a testament to leadership, dedication and expertise in the field
The UCI Office of Research is pleased to announce the Center for Translational Vision Research (CTVR)’s achievement of the prestigious Organized Research Unit (ORU) status at UCI.
Jul 10, 2024 | Ophthalmology Times
Marjan Farid, MD, recognized for eye care innovations
Marjan Farid, MD, received the Roger Steinert, MD, Legacy Award at the Octane Ophthalmology Tech Forum, held June 20-21 at the Newport Beach Marriott Hotel & Spa in Irvine, California.
Jun 24, 2024 | Ophthalmology Times
Magnetic cell therapy is a potential treatment option for corneal endothelial dysfunction
Magnetic cell delivery of human corneal endothelial cells (HCECs) to the anterior chamber seems to be a safe cell-based treatment that is exhibiting early signs of efficacy for corneal endothelial cell dysfunction, Sumit Garg, MD, ABO, reported at the American Society of Cataract and Refractive Surgery 2024 annual meeting in Boston, Massachusetts.